HIGHLIGHTS
- who: Luc Dekie from the Clario, Market Street, Suite, Philadelphia, PA, USA have published the Article: False Negative ECG Device Results May Increase the Risk of Adverse Events in Clinical Oncology Trials, in the Journal: (JOURNAL)
- what: The patient randomization status (pre- or post-randomization) was available for most ECGs, but the details of the trial design and the randomization codes were not known to Clario, and for purposes of patient confidentiality, none of the clinical characteristics nor demographics of the patients were known. This study extends these results by evaluating ECG device algorithm false . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.